Agilent Technologies and Strand Life Sciences Announce GeneSpring Development Agreement
SANTA CLARA, Calif., and BANGALORE, India, Aug. 20, 2007
Agilent Technologies Inc. (NYSE: A) today announced an agreement in which Strand Life Sciences will develop Agilent’s GeneSpring software. This move is designed to accelerate upgrades as Agilent aggressively addresses evolving customer needs. This agreement expands on an existing relationship between Stratagene Corp. and Strand. Stratagene was acquired by Agilent in June 2007.
“We are excited about this new partnership with Strand Life Sciences,” said Bruce von Herrmann, general manager and vice president of Agilent’s Software and Informatics Division. “Their expertise in delivering chemistry and biology software will accelerate our bioinformatics software development and move us toward our number-one goal of providing application and workflow solutions for customers.”
“Agilent is an ideal partner for us as we build out applications for systems biology and, more broadly, in drug discovery,” said Vijay Chandru, Ph.D., chairman and CEO of Strand Life Sciences. “Our proven Avadis platform will power the market-leading GeneSpring products and enable rapid development of new functionality and analysis capabilities. This relationship will give customers more reasons to choose GeneSpring as their data analysis solution.”
The first version of GeneSpring GX developed by Strand Life Sciences is scheduled for release in late 2007. Customers of Stratagene’s ArrayAssist software will be offered a migration path to this new version of GeneSpring. More information will be available at the Agilent Bioinformatics Conference, Sept. 27-28, in Berlin, Germany: agilent.com/chem/bioinformatics-berlin2007.
About Strand Life Sciences Pvt. Ltd.
Strand Life Sciences — Strand — is a premier life science informatics innovation company. Strand leverages its core strengths and intellectual property in data mining, predictive modeling, bioinformatics and computational chemistry to develop products and solutions for drug discovery. Strand’s products are built on the award-winning platform Avadis. More information about Strand is available on the Web at www.strandls.com.
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A) is the world’s premier measurement company and a technology leader in communications, electronics, life sciences and chemical analysis. The company’s 19,000 employees serve customers in more than 110 countries. Agilent had net revenue of $5.0 billion in fiscal year 2006. Information about Agilent is available on the Web at www.agilent.com.
